Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Cancer Causes Control. 2019 May 18;30(7):757–765. doi: 10.1007/s10552-019-01183-1

Figure 1. Derivation of sample size.

Figure 1.

25(OH)D 25-hydroxyvitamin D3, FOLFOX fluorouracil, leucovorin, oxaliplatin, SNP single-nucleotide polymorphism, TTP time to progression